Mankind Pharma Ltd share price logo

Mankind Pharma Ltd

NSE: MANKIND

BSE: 543904

Mid Cap

FMCG Sector

Healthcare Sector

Pharma Sector

₹2270.60

-9.90

(-0.43%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Block Trade Alert

Mankind Pharma Ltd. witnessed an NSE block trade of approximately 125,112 shares valued at Rs. 28.49 crore at Rs. 2276.90 per share

What are INDmoney investors doing with Mankind Pharma shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-51%

Searches for Mankind Pharma on INDmoney have decreased by 51% over the last 30 days.

Investment activity on INDmoney

-68.91%

Investment activity in Mankind Pharma among INDmoney users has decreased by 68.91% over the last 30 days.

Among the most traded stocks

208th

Mankind Pharma was the 208th most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

20 days

INDmoney investors hold Mankind Pharma shares for an average of 20 days.

Key Events for Mankind Pharma

Last Dividend Declared

₹1.00 per share, declared on 31/07/2025

View Dividend History

Mankind Pharma Stock Performance

as on September 16, 2026 at 6:39 pm IST

  • Day's Low

    Day's High

    ₹2,259.60
    ₹2,300.70
    downward going graph

    0.48%

    Downside

    1.33%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,909.70
    ₹2,674.00
    downward going graph

    15.89%

    Downside

    17.77%

    Upside

    downward going graph

Mankind Pharma share price movements today

Previous Close
₹2,280.50
Open
₹2,272.80
Volume
3.56L
Upper Circuit
₹2,508.50
Lower Circuit
₹2,052.50
Day's Low - High
₹2,259.60 - ₹2,300.70
52 Week Low - High
₹1,909.70 - ₹2,674.00

Mankind Pharma Historical Returns

1 Month Return
-4.22 %
3 Month Return
-3.21 %
1 Year Return
-11.26 %
3 Year Return
+ 31.48 %
5 Year Return
+ 60.34 %

Mankind Pharma Fundamentals

as on September 16, 2026 at 1:09 pm IST

Market Cap

₹94,194.93 Cr

Return on Equity (ROE)

13.27

PE Ratio (TTM)

46.07

Return on capital employed (ROCE)

13.07

Industry PE ratio

51.81

Beta (LTM)

0.68

P/B Ratio

5.05

Dividend Yield

0.05

PEG Ratio

15.83

Quarterly Earnings Growth YOY

29.12

EPS (TTM)

1938.23

Book Value

16301.46

Mankind Pharma Stock Valuation

as on September 16, 2026 at 1:09 pm IST

Mankind Pharma in the last 5 years

  • Overview

  • Trends

Lowest (40.63x)

August 5, 2024

Today (46.07x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (58.15x)

October 7, 2025

LowHigh

Today’s Price to Earnings Ratio: 46.07x

Mankind Pharma Technical Analysis

Track how Mankind Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish12
Bullish
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
-0.23
Bearish
CCI (20)
251.41
Bearish
RSI (14)
45.01
Neutral
Momentum (10)
-1.4
Bearish
ADI (14)
19.28
Neutral
Ultimate Oscillator (7,14,28)
32.17
Neutral

Moving Averages

Name

Value

Action

SMA (20)
2272.36
Bearish
EMA (20)
2271.8
Bearish
VWMA (20)
2271.99
Bearish
SMA (50)
2273.31
Bearish
EMA (50)
2272.01
Bearish
SMA (200)
2273.91
Bearish
EMA (200)
2273.99
Bearish
KAMA (200)
2271.44
Bearish
DEMA (200)
2271.94
Bearish

Mankind Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mankind Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Mankind Pharma Ltd image
Mankind Pharma Ltd
BUY94,194.9312.07%0.651,93814,277
Ipca Laboratories Ltd image
Ipca Laboratories Ltd
BUY49,025.8010.06%0.611,1919,646
J B Chemicals & Pharmaceuticals Ltd image
J B Chemicals & Pharmaceuticals Ltd
BUY38,676.9935.83%0.507094,147
Dr Reddys Laboratories Ltd image
Dr Reddys Laboratories Ltd
HOLD95,570.893.22%0.594,15733,700
Abbott India Ltd image
Abbott India Ltd
BUY55,515.634.88%0.001,4146,445
See all

Market expectation of Mankind Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

52.63%

Buy

26.32%

Hold

21.05%

Sell

Mankind Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
2,708.1
2,606.95
2,422.24
2,867.85
3,061.43
3,198.79
3,079.37
3,570.35
3,697.16
3,567.2
3,442.93
4,030.59
Other Income
63.45
74.73
94.56
107.9
111.63
87.09
253.65
83.05
94.19
75.96
117.28
48.94
Total Income
2,771.55
2,681.68
2,516.8
2,975.75
3,173.06
3,285.88
3,333.02
3,653.4
3,791.35
3,643.16
3,560.21
4,079.53
Expenses
2,025.45
2,000.45
1,836.27
2,196.29
2,216.61
2,382.8
2,400.52
2,723.58
2,775.83
2,754.36
2,536.21
2,974.4
Operating Profit
682.65
606.5
585.97
671.56
844.82
815.99
678.85
846.77
921.33
812.84
906.72
1,056.19
Operating Profit Margin %
25.21%
23.26%
24.19%
23.42%
27.6%
25.51%
22.05%
23.72%
24.92%
22.79%
26.34%
26.2%
Profit Before Interest, Tax and Depreciation
746.1
681.23
680.53
779.46
956.45
903.08
932.5
929.82
1,015.52
888.8
1,024
1,105.13
Interest
8.62
9.19
9.17
10.84
7.1
220.93
190.54
170.65
169.68
157.2
141.75
109.98
Depreciation
96.49
109.72
99.78
102.69
100.49
187.17
230.87
218.68
221.82
222.6
223.08
225.7
Profit Before Tax
640.99
562.32
571.58
665.93
848.86
494.98
511.09
540.49
624.02
509
659.17
769.45
Tax Paid
129.81
102.51
94.99
122.86
189.98
110.46
86.44
95.87
103.84
95.12
99.75
195.36
Profit After Tax
511.18
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
413.88
559.42
574.09
Total Net profit including share of profit / Loss from associate company
511.18
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
413.88
559.42
574.09
EPS
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
13.76
Actual EPS
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
13.76
Adjusted EPS
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
13.76
Diluted EPS
12.49
11.31
11.74
13.37
16.28
9.44
10.18
10.6
12.38
9.89
13.41
13.74

Mankind Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
5,865.23
6,214.43
7,781.56
8,749.43
10,260.44
12,207.44
14,277.64
Other Income
121.96
182.63
210.48
140.99
296.41
553.56
370.48
Total Income
5,987.19
6,397.06
7,992.03
8,890.42
10,556.85
12,761
14,648.12
Expenses
4,428.42
4,566.33
5,792.2
6,848.8
7,746.76
9,189.51
10,789.98
Operating Profit
1,436.81
1,648.1
1,989.36
1,900.63
2,513.68
3,017.93
3,487.66
Operating Profit Margin %
24.5%
26.52%
25.57%
21.72%
24.5%
24.72%
24.43%
Profit Before Interest, Tax and Depreciation
1,558.77
1,830.73
2,199.83
2,041.63
2,810.09
3,571.49
3,858.14
Interest
21.97
20.15
58.61
44.47
32.75
429.41
639.28
Depreciation
99.06
118.97
166.62
325.92
378.42
621.22
886.18
Profit Before Tax
1,437.74
1,691.61
1,974.6
1,671.24
2,398.92
2,520.86
2,332.68
Tax Paid
381.59
398.58
521.64
361.57
457.15
509.74
394.58
Profit After Tax
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
1,938.1
Total Net profit including share of profit / Loss from associate company
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
1,938.1
EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Actual EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Adjusted EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Diluted EPS
26.36
32.28
35.78
32
47.68
49.19
46.28

Mankind Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
1,069.71
1,137.24
919.78
1,813.3
2,152.44
2,413.38
3,121.29
Cash Flow from Investing Activities
-435.54
-1,221.85
-1,368.67
-1,051.82
-2,080.52
-12,624.07
-180.79
Cash Flow from Financing Activities
-530.74
-7.81
604.62
-739.72
5.27
10,232.56
-2,952.69
Net Cash Flow
103.42
-92.4
155.73
21.76
77.19
21.87
-12.19

Mankind Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
76.5%
74.88%
74.87%
74.87%
72.71%
72.7%
72.68%
72.67%
72.66%
72.66%
72.63%
DII
9.49%
11.14%
9.95%
9.9%
11.06%
11.48%
11.5%
11.92%
13.25%
14.46%
15.39%
FII
0%
9.87%
11.58%
12.37%
13.34%
12.92%
13.07%
12.84%
11.34%
10.24%
9.45%
Public
6.97%
4.11%
3.61%
2.86%
2.9%
2.9%
2.75%
2.57%
2.75%
2.64%
2.53%
Total Outstanding Shares
40,05,88,440
40,05,88,440
40,06,35,138
40,06,44,138
41,25,66,899
41,25,78,527
41,27,28,748
41,27,58,490
41,28,05,072
41,28,28,328
41,29,95,978
Total Shareholders
1,27,449
1,35,116
1,53,450
1,63,854
1,71,281
1,80,597
1,79,549
1,70,347
1,77,539
1,77,606
1,66,715

Mutual Funds Buying / Exiting Mankind Pharma

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Mankind Pharma

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Nippon India Growth Mid Cap Fund - Direct Plan - Growth Mid Cap

Nippon India Growth Mid Cap Fund - Direct Plan - Growth Mid Cap

₹885.53 Cr

₹106.19 Cr (+13.63%)

1.81%

Nippon India Large Cap Fund - Direct Plan - Growth Plan

Nippon India Large Cap Fund - Direct Plan - Growth Plan

₹439.27 Cr

₹47.07 Cr (+12.00%)

0.86%

Aditya Birla Sun Life Flexi Cap Fund Direct Plan Growth

Aditya Birla Sun Life Flexi Cap Fund Direct Plan Growth

₹401.90 Cr

₹25.97 Cr (+6.91%)

1.47%

Mutual Funds Exiting Mankind Pharma

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Mankind Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Mankind Pharma.

  • Mankind Pharma Ltd Earnings Results

    Mankind Pharma Ltd’s net profit jumped 29.6% since last year same period to ₹568.06Cr in the Q1 2026-2027. On a quarterly growth basis, Mankind Pharma Ltd has generated 2.47% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Mankind Pharma Ltd Dividends July,2025

    In the quarter ending June 2025, Mankind Pharma Ltd has declared dividend of ₹1.00 per share on 31 Jul 2025 - translating a dividend yield of 0.04%.

    Read More about Dividends

Indices Featuring Mankind Pharma Stock

Check stock indices that include Mankind Pharma.

S&P BSE 150 MidCap

₹16,528.11

+34.41 (▲0.21%)

Nifty 200

₹13,514.55

+72.30 (▲0.54%)

S&P BSE 400 MidSmallCap

₹12,423.23

+16.39 (▲0.13%)

BSE Healthcare

₹50,365.35

-113.46 (▲0.22%)

S&P BSE 250 LargeMidCap

₹10,424.03

+53.51 (▲0.52%)

Nifty LargeMidcap 250

₹16,153.40

+65.95 (▲0.41%)

BSE 200

₹10,929.71

+59.70 (▲0.55%)

Nifty 500

₹22,580.85

+103.40 (▲0.46%)

Nifty Healthcare

₹16,257.30

-41.70 (▲0.26%)

Nifty Midcap 150

₹22,402.85

+44.05 (▲0.20%)

Nifty Midcap 50

₹17,585.20

+28.85 (▲0.16%)

NIFTY PHARMA

₹26,107.45

-80.95 (▲0.31%)

Nifty Midcap 100

₹60,991.25

+113.00 (▲0.19%)

Nifty MidSmallcap 400

₹20,773.25

+22.55 (▲0.11%)

BSE 500

₹35,330.72

+161.10 (▲0.46%)

Insights on Mankind Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 408.75 Cr → 568.06 Cr (in ₹), with an average increase of 14.3% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 3.56K Cr → 4.07K Cr (in ₹), with an average increase of 12.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MANKIND stock has moved up by 0.7%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 10.36% to 10.87% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 2.64% to 2.53% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 72.66% to 72.63% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 10.24% to 9.45% in Jun 2026 quarter

Mankind Pharma Stock Futures & Options Contracts

View the latest movement in Mankind Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Mankind Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 29 Sep ₹2400 Call
September 29, 2026
₹2400
₹9.5
-2.3
-19.49%
MANKIND 29 Sep ₹2300 Call
September 29, 2026
₹2300
₹32.45
-5.35
-14.15%
MANKIND 29 Sep ₹2280 Call
September 29, 2026
₹2280
₹43.15
-3.8
-8.09%
MANKIND 29 Sep ₹2340 Call
September 29, 2026
₹2340
₹19.15
-4.25
-18.16%

Mankind Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 29 Sep Fut
September 29, 2026
-
₹2282.2
-5.49
-0.24%
MANKIND 27 Oct Fut
October 27, 2026
-
₹2292.5
-9.21
-0.4%
MANKIND 23 Nov Fut
November 23, 2026
-
₹2309.2
-2.31
-0.1%

About Mankind Pharma Ltd

Mankind Pharma Ltd. was established in 1991 as a Private Limited Company. In 2005 it was converted to a Public Limited Company and the name changed to Mankind Pharma Limited. The Company is engaged in the development, manufacturing and marketing of a range of pharmaceuticals and consumer healthcare products, and is active in acute and chronic therapeutic areas such as anti-infectives, cardiovascular and gastrointestinal treatments, antidiabetic and neuro/CNS medicines, vitamins, minerals and nutrients. In 2004, they entered the chronic pharmaceutical segment, and have added further products over the years, including ophthalmic products, consumer healthcare products, animal healthcare products and specialty therapeutic divisions. They operate 23 manufacturing facilities across India and had 2181 manufacturing personnel as of March 31, 2021. It is now planning to raise capital through the public offering of 40058844 equity shares, with a total installed capacity of 40.77 billion units across a range of products.

Revenue: ₹4,030.59Cr as on June 2026 (Q1 FY27)
Net Profit: ₹574.09Cr as on June 2026 (Q1 FY27)
Listing date: 09 May, 2023
Chairperson Name: RAMESH CHAND JUNEJA
OrganisationMankind Pharma Ltd
HeadquartersNew Delhi
IndustryPharmaceuticals
CEORAMESH CHAND JUNEJA
E-voting on sharesClick here to vote

FAQs

What is Mankind Pharma share price today?

Mankind Pharma share price today stands at ₹2270.6 as on . Mankind Pharma share today touched a day high of ₹2300.7 and a low of ₹2259.6.

What is the 52 week high and 52 week low range for Mankind Pharma share?

Mankind Pharma touched a 52 week high of ₹2674 and a 52 week low of ₹1909.7. Mankind Pharma share price today i.e. is trending at ₹2270.6, which is -15.09% down from its 52 week high and 18.90% up from its 52 week low.

What is Mankind Pharma's market capitalisation today?

Mankind Pharma market capitalisation is ₹94,194.93 Cr as on .

How to buy Mankind Pharma shares?

To buy Mankind Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MANKIND or Mankind Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Mankind Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Mankind Pharma trading volume today?

Mankind Pharma trading volume is 3.56L as on . This means that 3.56L shares of Mankind Pharma were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Mankind Pharma shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Mankind Pharma have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 20 days. This reflects platform activity only and is not investment advice.